The authors reply

New England Journal of Medicine

Volumn 361, Issue 22, 2009, Pages 2195-

  Oviedo Joekes, Eugenia ^a   Marsh, David ^b   Schechter, Martin T ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER COASTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; METHADONE;

CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; COST CONTROL; DRUG DOSE TITRATION; HUMAN; LETTER; OPIATE ADDICTION; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT RESPONSE;

EID: 72049107189     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc0908990     Document Type: Letter

References (5)

1. Ferri M, Davoli M, Perucci CA. Heroin maintenance for chronic heroin dependents. Cochrane Database Syst Rev 2005; 2:CD003410.
2. Haasen C, Vertheim U, Degkwitz P, et al. The German model project for heroin assisted treatment of opioid dependent patients: a multicentric, randomized, controlled treatment study. Hamburg, Germany: Centre for Interdisciplinary Addiction Research of Hamburg University (ZIS), 2006.
3. Siva N. Heroin clinics reduce street drug use and crime, shows study. BMJ 2009;339:b3845.
4. Dijkgraaf MG, van der Zanden BP, de Borgie CA, Blanken P, van Ree JM, van den Brink W. Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials. BMJ 2005; 330:1297. (Pubitemid 40813560)
5. Wall R, Rehm J, Fischer B, et al. Social costs of untreated opioid dependence. J Urban Health 2000;77:688-722. (Pubitemid 32059236)